R-Biopharm direct detection of C. difficile toxins A and B
04 August, 2010Article No. N0803 is a simple, one-step rapid test based on lateral flow technology that enables direct detection of C. difficile toxins A and B in well homogenised stool samples in 15 minutes. The test kit contains all utensils needed for successful assay performance and allows users to make 25 individual determinations. A positive control, which is not provided with the kit, can be ordered separately under Art. No. NP0804.
Oxoid Australia Xpect Legionella immunochromatographic test
03 June, 2010 byXpect Legionella is a rapid immunochromatographic test for the direct detection of Legionella pneumophila serogroups one and six antigen in human urine samples.
Myco Scan Mycoplasma testing kit
06 April, 2010
by
The Myco Scan Kit can be used to do rapid and reliable Mycoplasma contamination using real-time PCR.
Label-free, cell-based assays using clonetics cell systems and MDS Analytical Technologies’ CellKey System
01 April, 2010Label-free, cell-based assay platforms are innovative tools for assessing the integrated functional responses of cells to drug-like compounds.
BioPlex 2200 anti-CCP assay test
30 March, 2010 byThe BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.
Bio-Rad BioPlex 2200 Anti-CCP test
04 February, 2010 byBio-Rad Laboratories and Axis-Shield have launched Bio-Rad’s BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis. The assay, which will run on Bio-Rad’s BioPlex 2200 system, measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have superior specificity in the diagnosis of rheumatoid arthritis. The BioPlex 2200 Anti-CCP kit is based on Axis-Shield’s proprietary anti-CCP technology. The assay is available for sale in certain countries outside the US.
PerkinElmer GSP Genetic Screening Processor
04 February, 2010 byPerkinElmer has received 510K clearance from the US Food and Drug Administration for its GSP Genetic Screening Processor, which is used by public health laboratories worldwide as part of newborn screening programs.
Optical chip detects blood molecules
01 December, 2009A portable ‘lab on a chip’ that can identify target molecules in blood samples has been created by European researchers. It is being used to measure fertility hormones and detect the genes associated with certain types of cancer.
Analytik Jena molecular-genetic rapid pathogen identification
30 November, 2009 byAnalytik Jena has developed a molecular-genetic rapid test for the direct identification of pathogens, validated for its rapid cycler and the standard Biometra cycler.
Beckman Coulter Access Sex Hormone Binding Globulin (SHBG) assay
20 November, 2009 byBeckman Coulter has expanded its reproductive disease state management range with the Access Sex Hormone Binding Globulin (SHBG) assay for use in the differential diagnosis of conditions of chronic or excessive androgenic activity. The assay may also be used in conjunction with the Access Testosterone Assay to provide a calculated free androgen index1.
Enzo CELLestial fluorescent probes and labelling reagents
20 November, 2009 byEnzo Life Sciences’ CELLestial fluorescent probes and labelling reagents for live cell analysis applications include reagents for detection of pH, calcium, chloride, zinc, membrane potential, ROS, GPCR, amyloid and lipid droplets.
SensiGene Cystic Fibrosis (CF) Carrier Screening Test
20 November, 2009 byThe SensiGene Cystic Fibrosis (CF) Carrier Screening Test screens for 103 mutations and five variants, including the 23 mutations recommended by the American College of Medical Genetics (ACMG).
Qiagen Influenza A/H1N1 test kit
20 November, 2009 byQiagen has launch its Influenza A/H1N1 test and several updates to its activities in the global surveillance of the swine flu pandemic. The kit enables both the highly sensitive and specific detection of the novel Influenza A/H1N1 and all other known Influenza A and B virus strains. The test kit has been designed for use by governments and public health institutions.
Bio-Rad acquires Biotest diagnostics
20 November, 2009 byBio-Rad Laboratories has signed an agreement to acquire certain diagnostic businesses of Biotest for 45 million euros, the terms of which were not disclosed. The transaction is subject to closing conditions, including regulatory approvals, and is expected to close in the first quarter of 2010.
Millipore FlowCellect kits
20 November, 2009Three FlowCellect kits are now available for benchtop flow cytometry, targeted at key signalling pathways and said to provide the first complete validation for evaluating complex cell signalling events without sending samples to a core laboratory.
